La cardiomyopathie hypertrophique (CMH) est une maladie génétique de transmission autosomique dominante couramment traitée par inotropes négatifs. Report of the World Health Organisation/International Society and Federation of Cardiology Task force on the definition and classification of. High level of physical training can lead cardiovascular quantitative and qualitative adaptations. These clinical, electrical and echocardiographic adaptations are.

Author: Dikinos Ket
Country: Iran
Language: English (Spanish)
Genre: Finance
Published (Last): 7 August 2005
Pages: 364
PDF File Size: 18.30 Mb
ePub File Size: 16.75 Mb
ISBN: 638-3-48908-742-3
Downloads: 34694
Price: Free* [*Free Regsitration Required]
Uploader: Voodoomi

End-stage hypertrophic cardiomyopathy in a cat.

Journal page Archives Contents list. NMD, 27, 12, p.

American journal of human genetics The, 55, p. Surgical management of obstructive hypertrophic cardiomyopathy remain an important option in young patients, in case of failure of the ethanol septal ablation or in patients who present other surgical lesions.

The owners of this cardiokyopathie hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties. First mutation in cardiac troponin C, L29Q, in a patient with hypertrophic cardiomyopathy. The version of the gene table of monogenic neuromuscular disorders nuclear genome Kaplan JC, Hamroun D Neuromuscular disorders: As per the Law relating to information storage and personal integrity, you have the right to oppose art 26 of that lawaccess art 34 of that law and rectify art 36 of that law your personal data.

Risk stratification and prevention of sudden death in hypertrophic cardiomyopathy. Evolution of the surgical strategy in hypertrophic cardiomyopathy: Kaplan JCAuteur. Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: NMD, 3, 1, p Genetic testing and genetic counselling in hypertrophic cardiomyopathy: Prevalence of hypertrophic cardiomyopathy in a general population of young adults: Access to the PDF text.


Contact Help Who are we? Causes, athlete’s heart, and screening guidelines. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted. Cardiomyopayhie to the text HTML. Access to the full text of this article requires a subscription.

La cardiomyopathie hypertrophique familiale: If you want to subscribe to this journal, see our rates You can purchase this item in Pay Per View: European heart journal, 20, p. Synonyme s cardiomyopathie obstructive familiale ;familial hypertrophic myocardiopathy ;familial obstructive cardiomyopathy ;familial obstructive myocardiopathy ;myocardiopathie hypertrophique familiale ;myocardiopathie obstructive familiale ;familial HCM familial hypertrophic cardiomyopathy.

Access to the full text of this article caridomyopathie a subscription. Access to the PDF text. NMD, 23, 12, p. NMD, 24, 12, hypegtrophique. Modifier genes for hypertrophic cardiomyopathy. NMD, 25, p. There was an evolution in the surgical strategy to treat the patients who present a left ventricular outflow tract gradient.

End-stage hypertrophic cardiomyopathy in a cat.

Abstract Full text References Figures 1. Pre and post operative echocardiographic data were analysed. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.

Mutations in the gamma-2 subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: Personal information regarding our website’s visitors, including their identity, is confidential.


Alpha-cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy. You can move this window by clicking on the headline.

Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy. Truncated cardiac myosin-binding protein C are substrates cardiomyopatjie inhibitors of the ubiquitin-proteasome system abstract: If you are a subscriber, please sign in ‘My Account’ at the top right of the screen.

Cardiomyopathie hypertrophique – EM|consulte

Hypertrophic cardiomyopahty is an inherited disease characterized by a left ventricular hypertrophy, a diastolic dysfunction and rhythm troubles with risk of sudden death. Structural analysis of the titin gene in hypertrophic cardiomyopathy: If you are a subscriber, please sign in ‘My Account’ at the top right of the screen. NMD, 26, 12, p. Outline Masquer le plan. Top of the page.

Médecine thérapeutique Cardiologie

The authors and the editorial office regret the oversight of the journal reference under the title at the start of the Gene Table on page which should read: The dual chamber stimulation remain indicated in old patients. A new mouse model of familial hypertrophic cardiomyopathy exhibits instability of the EK mutant cardiac myosin-binding protein C abstract: New England Journal of Medicine The,Contact Help Who are we?

Journal page Archives Contents list. The patients were classified in four groups: